Speakers List

Workshop Leaders

Jessica Ingram

Managing Director
OPEN Health Medical Communications

Oliver Leatham

Vice President, Head of Value and Access

Julius de Roo

Director RWLP
Syneos Health

Luke Rogers

CEO & co-Founder                             
NextLevel Life Sciences                      

Geoff Cable

CEO & co-Founder                            
NextLevel Life Sciences  

Event Structure

Event Overview

Enabling Medical Teams to Critically Appraise Data

Day 1 - Workshop 1 - AM - 29th June, 2020

Market Access & Health Economics for Medical Affairs

Day 1 - Workshop 2 - PM - 29th June, 2020

Real-World and Late-Phase Studies in Practice

Day 2 - Workshop 3 - AM - 30th June, 2020

Soft Skills for Persuasion & Value Communication (Internal & External)

Day 2 - Workshop 4 - PM - 30th June, 2020

Medical Affairs, Medical Directors, Medical Science Liaison and field medical, Medical Advisors, Health Outcomes Liaison, KOL and External Stakeholder Engagement, Medical Communications, Publication & CME Executives.

Event Partners

Related Videos


Biopharmaceutical Acceleration Model for product development and commercialization

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs

Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK


Leveraging online discussion platforms for optimal KOL & Physician engagement

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global KOL engagement 
  • Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts 
  • Improving KOL engagement outcomes while maintaining regulatory compliance

Pauline De Mari
Vaccines Innovative Medical Engagement Lead

Andy Bowman
Managing Director

View Agenda or Register